30 Day Trial

Anika Therapeutics Transforms to Hybrid Commercial Model


Anika Therapeutics reports 3Q19 orthopedic revenue of USD $26.8MM, +11.1% vs. 3Q18.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.